Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
주권매매거래정지기간변경 (투자자 보호)
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement concerning the change of trading suspension period for a listed security, including specific fields such as subject security, reason for change, suspension periods, and regulatory basis. It does not contain financial statements, management discussion, dividend amounts, or board changes, nor is it a report publication notice. This fits the general regulatory filings category (RNS).
2026-05-20 Korean
기타시장안내 (상장폐지 절차 관련 안내)
Delisting Announcement Classification · 90% confidence The document is a notice informing investors about the status and procedural steps regarding the company’s stock delisting from the KOSDAQ market, including injunctions, suspension of procedures, and conditions under which trading will resume or delisting will occur. This clearly fits the definition of a Delisting Announcement (DLST).
2026-05-20 Korean
증권발행결과(자율공시) (제3자배정 유상증자-출자전환)
Share Issue/Capital Change Classification · 95% confidence The document is a voluntary disclosure of the results of a share issuance (third-party allocation paid-in capital increase by debt‐to‐equity conversion), detailing the number of shares issued, amounts, board resolution date, payment date, and listing intention. This falls squarely into the “Share Issue/Capital Change” category, Code: SHA.
2026-05-19 Welsh
최대주주변경
Major Shareholding Notification Classification · 85% confidence The document is a Korean stock exchange disclosure announcing a change in the company’s largest shareholder, detailing pre- and post-transaction share counts and ownership percentages. This fits the Major Shareholding Notification category, which covers notifications of changes in significant share ownership levels.
2026-05-19 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a Korean major event report (“주요사항보고서”) announcing and detailing the decision to increase capital via issuance of new shares (paid-in capital increase through third-party allotment). This falls squarely under “Share Issue/Capital Change (Code: SHA)”, which covers announcements of new share issues or other changes in capital structure.
2026-05-19 Korean
주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 89% confidence The document is a Korean “주요사항보고서” filed with the Financial Supervisory Service/Korea Exchange, detailing a capital reduction and share consolidation (reverse stock split) – including dates, ratios, procedures, and legal basis. This is not an Annual or Interim Report, nor a dividend or proxy statement. It specifically announces a change in the company’s capital and share structure. Under the classification taxonomy, this corresponds to “Share Issue/Capital Change” (SHA).
2026-05-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.